AW
IBRX icon

Avion Wealth’s ImmunityBio IBRX Stock Holding History

Avion Wealth’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6K Hold
866
– – ﹤0.01% 611
2025
Q4 		$1K Hold
866
– – ﹤0.01% 1047
2025
Q3 		$2K Sell
866
-353
-29% -$909 ﹤0.01% 859
2025
Q2 		$3K Buy
1,219
+353
+41% +$949 ﹤0.01% 725
2025
Q1 		$2K Hold
866
– – ﹤0.01% 720
2024
Q4 		$2K Hold
866
– – ﹤0.01% 717
2024
Q3 		$3K Hold
866
– – ﹤0.01% 612
2024
Q2 		$5K Sell
866
-62
-7% -$409 ﹤0.01% 462
2024
Q1 		$5K Sell
928
-109
-11% -$494 ﹤0.01% 461
2023
Q4 		$5K Buy
1,037
+341
+49% +$1.07K ﹤0.01% 398
2023
Q3 		$1K Buy
+696
New +$1.4K ﹤0.01% 653

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Avion Wealth's IBRX Position: Q1 2026 in Review

Avion Wealth held its ImmunityBio (IBRX) position steady in Q1 2026 at 866 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Avion Wealth first reported a position in IBRX in Q3 2023 and has held it in 11 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Avion Wealth held 866 shares of ImmunityBio worth $6K as of Q1 2026.
  • Avion Wealth left its ImmunityBio share count unchanged in Q1 2026.
  • ImmunityBio made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #611 holding.
  • Avion Wealth first reported a position in ImmunityBio in Q3 2023 and has held it in 11 quarters since.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.